14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for NRBO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.90 3.17 %
R2 3.83 1.36 %
R1 3.79 0.232 %
Current price: 3.78
Support S1 3.65 -3.41 %
S2 3.61 -4.53 %
S3 3.54 -6.35 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.62 22.22 %
R2 4.47 18.25 %
R1 4.43 17.20 %
Current price 3.78
Support S1 3.68 -2.65%
S2 3.61 -4.50%
S3 3.53 -6.61%

NRBO Predictions History

1 month ago
PredictionBot.Warren predicted that NRBO for Mar. 14th is going $4.61 (1.27%)

1 month ago
PredictionBot.Kathy predicted that NRBO for Mar. 14th is going $4.69 (3.08%)

1 month ago
fkldk.417249 predicted that NRBO for Mar. 14th is going

Rank:

2 months ago
PredictionBot.Kathy predicted that NRBO for Mar. 5th is going $6.29 (0.04%)

2 months ago
PredictionBot.Warren predicted that NRBO for Mar. 5th is going $6.38 (1.39%)

2 months ago
aiydanwebb.411726 predicted that NRBO for Mar. 5th is going

Rank:

2 years ago
Rybkarybka predicted that NRBO for 2021-11-01 is going $1.90 (-96.65%)

2 years ago
JS predicted that NRBO for 2021-10-07 is going $2.22 (-96.32%)

2 years ago
Rybkarybka predicted that NRBO for 2021-10-07 is going $2.30 (-96.19%)

2 years ago
JS predicted that NRBO for 2021-10-04 is going $2.60 (-96.34%)

Click to get the best stock tips daily for free!

About NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify ... NRBO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT